FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juompan, L.
Right arrow Articles by Zouali, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juompan, L.
Right arrow Articles by Zouali, M.
(The FASEB Journal. 1998;12:1473-1480.)
© 1998 FASEB


RESEARCH COMMUNICATION

Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection

Laure Juompana, Patrick Lambinb, and Moncef Zoualia,1

a Département d'Immunologie, Institut Pasteur, 75015 Paris, France
b Unité d'Immunologie Transfusionelle, INTS, 75015 Paris, France

HIV infection is characterized by accelerated apoptosis and progressive loss of B cells. To see whether these abnormalities are related to the property of gp120 to act as a superantigen for VH3+ B cells, we probed the temporal development of VH3+ antibodies in HIV-1-infected subjects over a 7-year period. We found that VH3+ antibodies specific for the gp120 superantigen binding site are deficient. Since VH3+ antibodies impart protective responses to infectious agents, we quantified VH3+ antibodies in serum samples from HIV-seropositive slow progressors and from patients who progressed to AIDS-related manifestations. We found that paucity in VH3+ antibodies is a marker of rapid clinical decline. Remarkably, anti-gp160 VH3+ antibodies showed a gradual decrease in progressors and, with time, varied depending on the viral load. We conclude that disease aggravation is associated with a decrease of the magnitude of the humoral response, that VH3+ antibodies play an important role in protection, and that their underexpression may accelerate disease progression. We propose that vaccine preparations able to trigger VH3+ antibodies might confer a better protection against HIV infection. This work also represents a novel mechanism of humoral deficiency resulting from the capacity of a viral antigen to affect an important subset of the B cell repertoire and to induce B cell death by apoptosis.—Juompan, L., Lambin, P., Zouali, M. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. FASEB J. 12, 1473–1480 (1998)


Key Words: B cell death • immunoglobulin isotypes • disease progression




This article has been cited by other articles:


Home page
haematolHome page
D. Capello, M. Martini, A. Gloghini, M. Cerri, S. Rasi, C. Deambrogi, D. Rossi, M. Spina, U. Tirelli, L. M. Larocca, et al.
Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis
Haematologica, August 1, 2008; 93(8): 1178 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Viau, N. S. Longo, P. E. Lipsky, and M. Zouali
Staphylococcal Protein A Deletes B-1a and Marginal Zone B Lymphocytes Expressing Human Immunoglobulins: An Immune Evasion Mechanism
J. Immunol., December 1, 2005; 175(11): 7719 - 7727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas, Y. Nishiyama, B. Handy, R. Hunter, A. Edmundson, and C. Hanson
Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120
J. Biol. Chem., September 17, 2004; 279(38): 39611 - 39619.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Viau, N. S. Longo, P. E. Lipsky, L. Bjorck, and M. Zouali
Specific In Vivo Deletion of B-Cell Subpopulations Expressing Human Immunoglobulins by the B-Cell Superantigen Protein L
Infect. Immun., June 1, 2004; 72(6): 3515 - 3523.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Hewson, J. J. Logie, P. Simmonds, and S. E. M. Howie
A CCR5-Dependent Novel Mechanism for Type 1 HIV gp120 Induced Loss of Macrophage Cell Surface CD4
J. Immunol., April 15, 2001; 166(8): 4835 - 4842.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff
Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells
J. Immunol., May 15, 2000; 164(10): 5482 - 5491.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The Federation of American Societies for Experimental Biology.